News about 'TB Diagnostics'

The Stop TB Partnership made two exciting announcements today: 1. US$ 40 million committed to roll-out of Xpert The executive board of UNITAID today approved funding of US$ 30 million to scale up access to Xpert MTB/RIF, and reduce the cost of its use. In addition, the Stop TB Partnership’s TB...

Click here for brochure. Vincent V, Rigouts L, Nduwamahoro E, Holmes B, Cunningham J, Guillerm M, Nathanson CM, Moussy F, De Jong B, Portaels F, Ramsay A. The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services. Int J Tuberc Lung Dis. 2012 Jan;16(1):...

A Dowsett, Health Protection Agency/Science Photo Library Vento S, Lanzafame M. Tuberculosis and cancer: a complex and dangerous liaison. Lancet Oncol. 2011 Jun;12(6):520-2. This week we review a commentary on the correlations between tuberculosis and cancer, specifically lung cancer. There are...

MIchael D. Iseman Dr. Michael D. Iseman, a world renowned pulmonologist and leading expert on tuberculosis has joined Oxford Immunotec as the Senior Scientific Advisor. To read full story, click here . In May 2010, the WGND had the honor of interviewing Dr. Iseman in our “Voices from the Fight to...

If you are having trouble viewing, click here . CORE Group Online Presentation about New TB Diagnostic Technology, Xpert®MTB/RI How does it work? Where can it be used? How might it make a difference in the global effort to stop TB? Hosted online by the CORE Group Tuberculosis Working Group on March...

2010 G-Finder Report The third annual G-Finder report, Neglected Disease Research and Development, was released on February 16, 2011. The report, compiled by the Policy Cures staff using information self-reported by granting and recipient institutions, provides the latest information on the funding...

5-Jul-2011 - 8-Jul-2011 | Montreal, Quebec, Canada Context High quality diagnostic studies are critical to evaluate new tools, to develop evidence-based policies on TB diagnostics. There is evidence that TB diagnostic trials are poorly conducted and poorly reported. Lack of methodologic rigour in...

WHO Press Conference Yesterday, Mario Raviglione , Director of Stop TB, and Giorgio Roscigno, CEO of FIND, held a global press conference announcing the World Health Organization’s endorsement of the new rapid diagnostic test Xpert MTB/RIF. If implemented to scale in countries where tuberculosis (...

New TB/HIV Working Group Report: Priority Research Questions for TB&HIV in HIV-Prevalent and Resource-Limited Settings TB-HIV Report Nov 2010 In November 2008, the Global TB/HIV Working Group of the Stop TB Partnership , in collaboration with the WHO Stop TB and HIV/AIDS departments and the...

This story originally appeared on BBC News. Click here to view . By Neil Bowdler Science reporter, BBC News A coloured micrograph of a cross-section of the tuberculosis bacteria Scientists in the UK say they have devised a new ultra-sensitive test which can diagnose the presence of the tuberculosis...

Genotype MTBDRplus assay kit Last week we highlighted the Xpert® MTB/RIF assay for diagnostic testing . This week, we will briefly describe the GenoType® MTBDR plus assay . The GenoType® MTBDR plus assay uses PCR to amplify biotin-labeled amplicons (single-stranded DNA sequences) of M. tb from...